Olanzapine compared to quetiapine in adolescents with a first psychotic episode

European Child and Adolescent Psychiatry

Volumn 18, Issue 7, 2009, Pages 418-428

  Arango, Celso ^a   Robles, Olalla ^a   Parellada, Mara ^a   Fraguas, David ^b   Ruiz Sancho, Ana ^a   Medina, Oscar ^a   Zabala, Arantzazu ^a   Bombín, Igor ^c   Moreno, Dolores ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^c Neurological Rehabilitation Center   (Spain)

Author keywords

Adolescent; First episode psychosis; Olanzapine; Quetiapine; Safety; Tolerability

Indexed keywords

OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADOLESCENT; AGGRESSION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LABORATORY TEST; MALE; MEDICAL RECORD; MUSCLE CONTRACTURE; POLYARTHRITIS; PRESCRIPTION; PSYCHOSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SIDE EFFECT; TREATMENT OUTCOME; VITAL SIGN; WEIGHT GAIN; WRIST FRACTURE;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIBENZOTHIAZEPINES; FEMALE; HUMANS; MALE; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 67349114862     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-009-0749-5     Document Type: Article

References (42)

1. C Arango M Parellada DM Moreno 2004 Clinical effectiveness of new generation antipsychotics in adolescent patients Eur Neuropsychopharmacol 14 S471 S479 (Pubitemid 39574339)
2. TR Barnes 2003 The Barnes Akathisia rating scale-revisited J Psychopharmacol 17 365 370
3. RR Conley DL Kelly 2005 Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects Isr J Psychiatry Relat Sci 42 51 60 (Pubitemid 41159764)
4. CU Correll AK Malhotra 2004 Pharmacogenetics of antipsychotic-induced weight gain Psychopharmacology (Berl) 174 477 489 (Pubitemid 39119337)
5. CU Correll JB Penzner UH Parikh T Mughal T Javed M Carbon AK Malhotra 2006 Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents Child Adolesc Psychiatr Clin N Am 15 177 206 (Pubitemid 41735243)
6. A Charach T Volpe KM Boydell RE Gearing 2008 A theoretical approach to medication adherence for children and youth with psychiatric disorders Harv Rev Psychiatry 16 126 135
7. VJ Fedorowicz E Fombonne 2005 Metabolic side effects of atypical antipsychotics in children: a literature review J Psychopharmacol 19 533 550 (Pubitemid 41392308)
8. RL Findling 2005 Update on the treatment of bipolar disorder in children and adolescents Eur Psychiatry 20 87 91 (Pubitemid 40409931)
9. RL Findling NK tmp McNamara EA Youngstrom LA Branicky CA Demeter SC Schulz 2003 A prospective, open-label trial of olanzapine in adolescents with schizophrenia J Am Acad Child Adolesc Psychiatry. 42 170 175 (Pubitemid 39610596)
10. D Fraguas J Merchan-Naranjo P Laita M Parellada D Moreno A Ruiz-Sancho A Cifuentes M Giraldez C Arango 2008 Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics J Clin Psychiatry 69 1166 1175
11. R Goodman 1999 The extended version of the strengths and difficulties questionnaire as a guide to child psychiatric caseness and consequent burden J Child Psychol Psychiatry 40 791 799 (Pubitemid 29341355)
12. R Goodman 1997 The strengths and difficulties questionnaire: a research note J Child Psychol Psychiatry 38 581 586 (Pubitemid 27341892)
13. D Gothelf A Apter J Reidman A Brand-Gothelf Y Bloch G Gal L Kikinzon S Tyano R Weizman G Ratzoni 2003 Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia J Neural Transm 110 545 560 (Pubitemid 36543285)
14. Guy W (1976) Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology revised. National Institute of Mental Health, Rockville
15. M Hamilton 1967 Development of a rating scale for primary depressive illness Br J Soc Clin Psychol 6 278 296
16. PB Jones TR Barnes L Davies G Dunn H Lloyd KP Hayhurst RM Murray A Markwick SW Lewis 2006 Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1) Arch Gen Psychiatry 63 1079 1087 (Pubitemid 44498387)
17. RS Kahn WW Fleischhacker H Boter M Davidson Y Vergouwe IP Keet MD Gheorghe JK Rybakowski S Galderisi J Libiger M Hummer S Dollfus JJ Lopez-Ibor LG Hranov W Gaebel J Peuskens N Lindefors A Riecher-Rossler DE Grobbee 2008 Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial Lancet 371 1085 1097
18. Kay SR, Opler LA, Lindenmayer JP (1989) The positive and negative syndrome scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl, pp 59-67
19. RS Keefe JA Sweeney H Gu RM Hamer DO Perkins JP tmp McEvoy JA Lieberman 2007 Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison Am J Psychiatry 164 1061 1071 (Pubitemid 47121395)
20. LC Kopala KP Good H Milliken C Buiteman H Woodley Q Rui D Whitehorn L Love R Balshaw I Kiss WG Honer 2006 Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes Schizophr Res 81 29 39 (Pubitemid 41817204)
21. S Kumra JA Frazier LK Jacobsen K tmp McKenna CT Gordon MC Lenane SD Hamburger AK Smith KE Albus J Alaghband-Rad JL Rapoport 1996 Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison Arch Gen Psychiatry 53 1090 1097 (Pubitemid 26422059)
22. P Laita A Cifuentes A Doll C Llorente I Cortes M Parellada D Moreno A Ruiz-Sancho M Graell C Arango 2007 Antipsychotic-related abnormal involuntary movements and metabolic and endocrine side effects in children and adolescents J Child Adolesc Psychopharmacol 17 487 502 (Pubitemid 47417776)
23. JA Lieberman TS Stroup JP tmp McEvoy MS Swartz RA Rosenheck DO Perkins RS Keefe SM Davis CE Davis BD Lebowitz J Severe JK Hsiao 2005 Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med 353 1209 1223 (Pubitemid 41345943)
24. JA Lieberman G Tollefson M Tohen AI Green RE Gur R Kahn J tmp McEvoy D Perkins T Sharma R Zipursky H Wei RM Hamer 2003 Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol Am J Psychiatry 160 1396 1404 (Pubitemid 41070913)
25. O Lingjaerde UG Ahlfors P Bech SJ Dencker K Elgen 1987 The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients Acta Psychiatr Scand Suppl 334 1 100 (Pubitemid 17115352)
26. B tmp McConville L Carrero D Sweitzer L Potter R Chaney K Foster M Sorter L Friedman K Browne 2003 Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial J Child Adolesc Psychopharmacol 13 75 82 (Pubitemid 36570190)
27. BJ tmp McConville LA Arvanitis PT Thyrum C Yeh LA Wilkinson RO Chaney KD Foster MT Sorter LM Friedman KL Brown JE Heubi 2000 Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders J Clin Psychiatry 61 252 260 (Pubitemid 30305366)
28. Mozes 2006 J Child Adolesc Psychopharmacol 16 393
29. T Mozes P Toren N Chernauzan R Mester R Yoran-Hegesh R Blumensohn A Weizman 1994 Clozapine treatment in very early onset schizophrenia J Am Acad Child Adolesc Psychiatry 33 65 70 (Pubitemid 24017219)
30. Naber D, Karow A, Lambert M (2005) Subjective well-being under the neuroleptic treatment and its relevance for compliance. Acta Psychiatr Scand Suppl, pp 29-34
31. D Naber S Moritz M Lambert FG Pajonk R Holzbach R Mass B Andresen 2001 Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs Schizophr Res 50 79 88 (Pubitemid 32510889)
32. M Olfson C Blanco L Liu C Moreno G Laje 2006 National trends in the outpatient treatment of children and adolescents with antipsychotic drugs Arch Gen Psychiatry 63 679 685 (Pubitemid 43848299)
33. SE Purdon M Snaterse 1998 Selective serotonin reuptake inhibitor modulation of clozapine effects on cognition in schizophrenia Can J Psychiatry 43 84 85 (Pubitemid 28125134)
34. SM Sengupta R Klink E Stip T Baptista A Malla R Joober 2005 Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naive patients with psychotic disorders Schizophr Res 80 131 133 (Pubitemid 41587471)
35. D Shaffer MS Gould J Brasic P Ambrosini P Fisher H Bird S Aluwahlia 1983 A children's global assessment scale (CGAS) Arch Gen Psychiatry 40 1228 1231
36. JA Shaw JE Lewis S Pascal RK Sharma RA Rodriguez R Guillen M Pupo-Guillen 2001 A study of quetiapine: efficacy and tolerability in psychotic adolescents J Child Adolesc Psychopharmacol 11 415 424 (Pubitemid 34117291)
37. P Shaw A Sporn N Gogtay GP Overman D Greenstein P Gochman JW Tossell M Lenane JL Rapoport 2006 Childhood-onset schizophrenia: a double-blind, randomized clozapine-olanzapine comparison Arch Gen Psychiatry 63 721 730
38. L Sikich RM Hamer RA Bashford BB Sheitman JA Lieberman 2004 A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial Neuropsychopharmacology 29 133 145 (Pubitemid 38068023)
39. GM Simpson JW Angus 1970 A rating scale for extrapyramidal side effects Acta Psychiatr Scand Suppl 212 11 19
40. DI Velligan J Newcomer J Pultz J Csernansky AL Hoff R Mahurin AL Miller 2002 Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr Res 53 239 248 (Pubitemid 34008588)
41. LP Voruganti AG Awad G Parker C Forrest Y Usmani ML Fernando S Senthilal 2007 Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine Schizophr Res 96 146 155 (Pubitemid 47494646)
42. RC Young JT Biggs VE Ziegler DA Meyer 1978 A rating scale for mania: reliability, validity and sensitivity Br J Psychiatry 133 429 435 (Pubitemid 9006756)